Screening and treating pregnant patients for three common sexually transmitted infections (STIs) twice during pregnancy was associated with a 23% lower risk of preterm birth compared with standard care, according to a randomized clinical trial published in Clinical Infectious Diseases from researchers at the University of Pennsylvania and University of Southern California.
STI Screening During Pregnancy Reduces Preterm Birth Risk by 23%
A clinical trial found that screening and treating pregnant patients for common STIs reduced the risk of preterm birth by 23%. Researchers from the University of Pennsylvania and University of Southern California conducted the study. This finding is significant for Iran as it highlights the importance of healthcare interventions in improving maternal and infant health outcomes.
👥 Key Players
📰 What Happened
A clinical trial found that screening and treating pregnant women for common STIs significantly reduced the risk of preterm birth. The study showed a 23% decrease in preterm birth rates compared to standard care.
- The study was published in the journal Clinical Infectious Diseases.
- The trial involved screening for three common STIs.
💡 Why It Matters
📚 Background
Preterm birth is a major cause of infant mortality and long-term health issues. Screening for STIs is a preventive measure that can improve health outcomes for mothers and infants.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%